- Home
- CCBG vs GOSS Comparison
CCBG vs GOSS Comparison
Compare CCBG & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- GOSS
- Stock Information
- Founded
- CCBG 1895
- GOSS 2015
- Country
- CCBG United States
- GOSS United States
- Employees
- CCBG N/A
- GOSS N/A
- Industry
- CCBG Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- GOSS Health Care
- Exchange
- CCBG Nasdaq
- GOSS Nasdaq
- Market Cap
- CCBG 712.5M
- GOSS 586.6M
- IPO Year
- CCBG N/A
- GOSS 2019
- Fundamental
- Price
- CCBG $43.00
- GOSS $2.48
- Analyst Decision
- CCBG Buy
- GOSS Strong Buy
- Analyst Count
- CCBG 1
- GOSS 6
- Target Price
- CCBG $45.00
- GOSS $8.60
- AVG Volume (30 Days)
- CCBG 57.0K
- GOSS 4.6M
- Earning Date
- CCBG 10-21-2025
- GOSS 11-06-2025
- Dividend Yield
- CCBG 2.27%
- GOSS N/A
- EPS Growth
- CCBG 14.00
- GOSS N/A
- EPS
- CCBG 3.42
- GOSS N/A
- Revenue
- CCBG $240,944,000.00
- GOSS $40,237,000.00
- Revenue This Year
- CCBG $11.91
- GOSS N/A
- Revenue Next Year
- CCBG $3.57
- GOSS $34.10
- P/E Ratio
- CCBG $12.37
- GOSS N/A
- Revenue Growth
- CCBG 8.96
- GOSS N/A
- 52 Week Low
- CCBG $32.38
- GOSS $0.66
- 52 Week High
- CCBG $44.69
- GOSS $3.60
- Technical
- Relative Strength Index (RSI)
- CCBG 57.25
- GOSS 43.54
- Support Level
- CCBG $41.15
- GOSS $2.32
- Resistance Level
- CCBG $41.94
- GOSS $2.64
- Average True Range (ATR)
- CCBG 0.79
- GOSS 0.19
- MACD
- CCBG -0.10
- GOSS -0.10
- Stochastic Oscillator
- CCBG 56.27
- GOSS 16.29
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.